169 related articles for article (PubMed ID: 12070251)
41. Gonadal sex cord stromal tumor in a patient with Rubinstein-Taybi syndrome.
Kurosawa K; Fukutani K; Masuno M; Kawame H; Ochiai Y
Pediatr Int; 2002 Jun; 44(3):330-2. PubMed ID: 11982910
[No Abstract] [Full Text] [Related]
42. A case of Rubinstein-Taybi syndrome associated with growth hormone deficiency in childhood.
Tornese G; Marzuillo P; Pellegrin MC; Germani C; Faleschini E; Zennaro F; Grandone A; Miraglia del Giudice E; Perrone L; Ventura A
Clin Endocrinol (Oxf); 2015 Sep; 83(3):437-9. PubMed ID: 25683362
[No Abstract] [Full Text] [Related]
43. Duplication of the Rubinstein-Taybi region on 16p13.3 is associated with a distinctive phenotype.
Marangi G; Leuzzi V; Orteschi D; Grimaldi ME; Lecce R; Neri G; Zollino M
Am J Med Genet A; 2008 Sep; 146A(18):2313-7. PubMed ID: 18688873
[TBL] [Abstract][Full Text] [Related]
44. CBP, a transcriptional coactivator and acetyltransferase.
McManus KJ; Hendzel MJ
Biochem Cell Biol; 2001; 79(3):253-66. PubMed ID: 11467739
[TBL] [Abstract][Full Text] [Related]
45. [CREBBP gene mutation in two boys with Rubinstein-Taybi syndrome].
Zhang J; Wang C; Li M; Qiu Z
Zhonghua Er Ke Za Zhi; 2014 Sep; 52(9):673-7. PubMed ID: 25476429
[TBL] [Abstract][Full Text] [Related]
46. What's right with my mouse model? New insights into the molecular and cellular basis of cognition from mouse models of Rubinstein-Taybi Syndrome.
Josselyn SA
Learn Mem; 2005; 12(2):80-3. PubMed ID: 15805305
[No Abstract] [Full Text] [Related]
47. Chromosome aberrations in Rubinstein-Taybi syndrome.
Imaizumi K; Kurosawa K; Masuno M; Tsukahara M; Kuroki Y
Clin Genet; 1993 Apr; 43(4):215-6. PubMed ID: 8330456
[No Abstract] [Full Text] [Related]
48. From Whole Gene Deletion to Point Mutations of EP300-Positive Rubinstein-Taybi Patients: New Insights into the Mutational Spectrum and Peculiar Clinical Hallmarks.
Negri G; Magini P; Milani D; Colapietro P; Rusconi D; Scarano E; Bonati MT; Priolo M; Crippa M; Mazzanti L; Wischmeijer A; Tamburrino F; Pippucci T; Finelli P; Larizza L; Gervasini C
Hum Mutat; 2016 Feb; 37(2):175-83. PubMed ID: 26486927
[TBL] [Abstract][Full Text] [Related]
49. Rubinstein-Taybi syndrome (CREBBP, EP300).
van Belzen M; Bartsch O; Lacombe D; Peters DJ; Hennekam RC
Eur J Hum Genet; 2011 Jan; 19(1):preceeding 118-20. PubMed ID: 20664634
[No Abstract] [Full Text] [Related]
50. Rubinstein-Taybi syndrome with deletions of FISH probe RT1 at 16p13.3: two UK patients.
McGaughran JM; Gaunt L; Dore J; Petrij F; Dauwerse HG; Donnai D
J Med Genet; 1996 Jan; 33(1):82-3. PubMed ID: 8825057
[TBL] [Abstract][Full Text] [Related]
51. Evidence for a new contiguous gene syndrome, the chromosome 16p13.3 deletion syndrome alias severe Rubinstein-Taybi syndrome.
Bartsch O; Rasi S; Delicado A; Dyack S; Neumann LM; Seemanová E; Volleth M; Haaf T; Kalscheuer VM
Hum Genet; 2006 Sep; 120(2):179-86. PubMed ID: 16783566
[TBL] [Abstract][Full Text] [Related]
52. A case with Rubinstein-Taybi syndrome: A novel frameshift mutation in the CREBBP gene.
Eser M; Ayaz A; Yeşil G
Turk J Pediatr; 2017; 59(5):601-603. PubMed ID: 29745126
[TBL] [Abstract][Full Text] [Related]
53. p300/CBP and cancer.
Iyer NG; Ozdag H; Caldas C
Oncogene; 2004 May; 23(24):4225-31. PubMed ID: 15156177
[TBL] [Abstract][Full Text] [Related]
54. Rubinstein-Taybi syndrome and Hirschsprung disease in a patient harboring an intragenic deletion of the CREBBP gene.
Isidor B; Podevin G; Camby C; Mosnier JF; Chauty A; Lyet JM; Fergelot P; Lacombe D; Arveiler B; Pelet A; Amiel J; David A
Am J Med Genet A; 2010 Jul; 152A(7):1847-8. PubMed ID: 20583168
[No Abstract] [Full Text] [Related]
55. [Rubinstein-Taybi syndrome: a familial form ].
El Hafidi N; Ghanimi Z; Gaouzi A; Benhamou B; Alaoui-M'sseffer F
Arch Pediatr; 2004 Aug; 11(8):978-9. PubMed ID: 15288097
[No Abstract] [Full Text] [Related]
56. [Molecular diagnosis of multiple malformation syndrome].
Torii C; Kosaki K
Nihon Rinsho; 2005 Dec; 63 Suppl 12():431-6. PubMed ID: 16416829
[No Abstract] [Full Text] [Related]
57. Deletion at chromosome 16p13.3 as a cause of Rubinstein-Taybi syndrome: clinical aspects.
Hennekam RC; Tilanus M; Hamel BC; Voshart-van Heeren H; Mariman EC; van Beersum SE; van den Boogaard MJ; Breuning MH
Am J Hum Genet; 1993 Feb; 52(2):255-62. PubMed ID: 8430692
[TBL] [Abstract][Full Text] [Related]
58. Histone acetylation deficits in lymphoblastoid cell lines from patients with Rubinstein-Taybi syndrome.
Lopez-Atalaya JP; Gervasini C; Mottadelli F; Spena S; Piccione M; Scarano G; Selicorni A; Barco A; Larizza L
J Med Genet; 2012 Jan; 49(1):66-74. PubMed ID: 21984751
[TBL] [Abstract][Full Text] [Related]
59. Cryptic microdeletion of the CREBBP gene from t(1;16) (p36.2;p13.3) as a novel genetic defect causing Rubinstein-Taybi syndrome.
Kim SR; Kim HJ; Kim YJ; Kwon JY; Kim JW; Kim SH
Ann Clin Lab Sci; 2013; 43(4):450-6. PubMed ID: 24247805
[TBL] [Abstract][Full Text] [Related]
60. Rubinstein-Taybi syndrome with de novo reciprocal translocation t(2;16)(p13.3;p13.3).
Imaizumi K; Kuroki Y
Am J Med Genet; 1991 Mar; 38(4):636-9. PubMed ID: 2063911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
